Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
22.74
+0.24 (1.07%)
At close: Jan 20, 2026, 4:00 PM EST
22.31
-0.43 (-1.89%)
After-hours: Jan 20, 2026, 7:30 PM EST
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 12 analysts that cover Alignment Healthcare stock have a consensus rating of "Buy" and an average price target of $21.63, which forecasts a -4.88% decrease in the stock price over the next year. The lowest target is $17 and the highest is $30.
Price Target: $21.63 (-4.88%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 4 |
| Buy | 5 | 5 | 4 | 5 | 6 | 6 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +9.94% | Jan 16, 2026 |
| UBS | UBS | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | -7.65% | Jan 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +31.93% | Jan 6, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +1.14% | Dec 17, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $18 → $20 | Hold → Buy | Upgrades | $18 → $20 | -12.05% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
4.02B
from 2.70B
Increased by 48.62%
Revenue Next Year
5.31B
from 4.02B
Increased by 32.25%
EPS This Year
0.24
from -0.67
EPS Next Year
0.08
from 0.24
Decreased by -64.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1B | 5.8B | |||
| Avg | 4.0B | 5.3B | |||
| Low | 3.9B | 4.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 53.2% | 44.6% | |||
| Avg | 48.6% | 32.3% | |||
| Low | 42.6% | 20.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.29 | 0.16 | ||
| Avg | 0.24 | 0.08 | ||
| Low | 0.19 | - |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | -33.6% | ||
| Avg | - | -64.7% | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.